Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Alain, Livartowski"'
Autor:
Nuria Lara, Montserrat Roset, Fiona Blackhall, Nicolas Girard, Laura McDonald, Alain Livartowski, Ariadna Juarez García
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Objective Describe characteristics, treatment patterns and clinical outcomes of patients with small-cell lung cancer (SCLC).Design Retrospective chart review study defining several cohorts: (1) limited-stage disease (LD) SCLC initiating 1L therapy (1
Externí odkaz:
https://doaj.org/article/9bb28ed16b424cbfb7efd814eaac5811
Autor:
Jean Ogier du Terrail, Armand Leopold, Clément Joly, Constance Béguier, Mathieu Andreux, Charles Maussion, Benoît Schmauch, Eric W. Tramel, Etienne Bendjebbar, Mikhail Zaslavskiy, Gilles Wainrib, Maud Milder, Julie Gervasoni, Julien Guerin, Thierry Durand, Alain Livartowski, Kelvin Moutet, Clément Gautier, Inal Djafar, Anne-Laure Moisson, Camille Marini, Mathieu Galtier, Félix Balazard, Rémy Dubois, Jeverson Moreira, Antoine Simon, Damien Drubay, Magali Lacroix-Triki, Camille Franchet, Guillaume Bataillon, Pierre-Etienne Heudel
Publikováno v:
Nature Medicine. 29:135-146
Autor:
Emmanuelle Kempf, Morgan Vaterkowski, Damien Leprovost, Nicolas Griffon, David Ouagne, Stéphane Breant, Patricia Serre, Alexandre Mouchet, Bastien Rance, Gilles Chatellier, Ali Bellamine, Marie Frank, Julien Guerin, Xavier Tannier, Alain Livartowski, Martin Hilka, Christel Daniel
Publikováno v:
JCO Clinical Cancer Informatics
JCO Clinical Cancer Informatics, 2023, 7, ⟨10.1200/CCI.22.00179⟩
JCO Clinical Cancer Informatics, 2023, 7, ⟨10.1200/CCI.22.00179⟩
PURPOSE To compare the computability of Observational Medical Outcomes Partnership (OMOP)–based queries related to prescreening of patients using two versions of the OMOP common data model (CDM; v5.3 and v5.4) and to assess the performance of the G
Autor:
Leila Zemoura, Damien Treguer, Nicolas Girard, Marie Brevet, A. Chapelier, Didier Decaudin, Olivier Deas, Sophie Chateau-Joubert, Stefano Cairo, Rania El Botty, Sergio Roman-Roman, André Nicolas, Didier Meseure, Ivan Bièche, Sophie Vacher, Ludmilla de Plater, Elodie Montaudon, Elisabetta Marangoni, Catherine Daniel, Fariba Nemati, Adnan Naguez, Alain Livartowski
Publikováno v:
Oncotarget. 12:859-872
Significant rational is available for specific targeting of PI3K/AKT/mTOR pathway in the treatment of non-small cell lung cancer (NSCLC). However, almost all clinical trials that have evaluated Pi3K pathway-based monotherapies/combinations did not ob
Publikováno v:
Computational Statistics
Computational Statistics, Springer Verlag, In press, ⟨10.1007/s00180-020-01008-9⟩
Computational Statistics, In press, ⟨10.1007/s00180-020-01008-9⟩
Computational Statistics, Springer Verlag, In press, ⟨10.1007/s00180-020-01008-9⟩
Computational Statistics, In press, ⟨10.1007/s00180-020-01008-9⟩
Count data is becoming more and more ubiquitous in a wide range of applications, with datasets growing both in size and in dimension. In this context, an increasing amount of work is dedicated to the construction of statistical models directly accoun
Autor:
Fiona Blackhall, Nicolas Girard, Alain Livartowski, Laura McDonald, Montserrat Roset, Nuria Lara, Ariadna Juarez García
Publikováno v:
BMJ Open. 13:e052556
ObjectiveDescribe characteristics, treatment patterns and clinical outcomes of patients with small-cell lung cancer (SCLC).DesignRetrospective chart review study defining several cohorts: (1) limited-stage disease (LD) SCLC initiating 1L therapy (1 L
Autor:
Elodie, Montaudon, Rania, El Botty, Sophie, Vacher, Olivier, Déas, Adnan, Naguez, Sophie, Chateau-Joubert, Damien, Treguer, Ludmilla, de Plater, Leïla, Zemoura, Fariba, Némati, André, Nicolas, Alain, Chapelier, Alain, Livartowski, Stefano, Cairo, Catherine, Daniel, Marie, Brevet, Elisabetta, Marangoni, Didier, Meseure, Sergio, Roman-Roman, Ivan, Bieche, Nicolas, Girard, Didier, Decaudin
Publikováno v:
Oncotarget
Significant rational is available for specific targeting of PI3K/AKT/mTOR pathway in the treatment of non-small cell lung cancer (NSCLC). However, almost all clinical trials that have evaluated Pi3K pathway-based monotherapies/combinations did not ob
Autor:
Joshua J. Waterfall, Anne Vincent-Salomon, François-Clément Bidard, Alain Livartowski, Delphine Guillemot, Odette Mariani, Camille Benoist, Sylvain Baulande, Gaëlle Pierron, Christophe Le Tourneau, Sarah Watson, Julien Vibert, Olivier Delattre, Nadège Gruel
Publikováno v:
The Journal of molecular diagnostics : JMD
The Journal of molecular diagnostics : JMD, 2021, 23 (10), pp.1380-1392. ⟨10.1016/j.jmoldx.2021.07.009⟩
The Journal of molecular diagnostics : JMD, 2021, 23 (10), pp.1380-1392. ⟨10.1016/j.jmoldx.2021.07.009⟩
International audience; Cancers of unknown primary (CUP) are metastatic cancers for which the primary tumor is not found despite thorough diagnostic investigations. Multiple molecular assays have been proposed to identify the tissue of origin (TOO) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d1d9c7bf93b95941ed6c068c99bacb
https://hal.archives-ouvertes.fr/hal-03434961
https://hal.archives-ouvertes.fr/hal-03434961
Autor:
Jean Ogier du Terrail, Armand Leopold, Clément Joly, Mathieu Andreux, Charles Maussion, Benoit Schmauch, Mikhail Zaslavskiy, Gilles Wainrib, Maud Milder, Julie Gervasoni, Julien Guérin, Thierry Durand, Alain Livartowski, Kelvin Moutet, Clément Gautier, Anne-Laure Moisson, Camille Marini, Mathieu Galtier, Pierre Etienne Heudel, Guillaume Bataillon
Publikováno v:
Journal of Clinical Oncology. 40:590-590
590 Background: Triple-Negative Breast Cancer (TNBC) is characterized by high metastatic potential and poor prognosis with limited treatment options. Neoadjuvant chemotherapy (NACT) is the standard of care in non-metastastic setting due to the abilit
Autor:
Alain Livartowski
Publikováno v:
Healthcare and Artificial Intelligence ISBN: 9783030321604
As is the case in other sectors health will benefit from technologies resulting from Big Data and artificial intelligence. Cancer is one of the pathologies that will benefit most because it is a very diverse family of diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a586e963bc72575b1057e64eeac0360
https://doi.org/10.1007/978-3-030-32161-1_9
https://doi.org/10.1007/978-3-030-32161-1_9